What is the translation of " DEFERIPRON " in English?

• deferiprone

Examples of using Deferipron in Swedish and their translations into English

En tablett innehåller 500 mg deferipron.
One tablet contains 500 mg deferiprone.

Deferipron är det aktiva innehållsämnet i Ferriprox.
Deferiprone is the active substance in Ferriprox.

Varje tablett innehåller 500 mg deferipron.
Each tablet contains 500 mg deferiprone.

Deferipron får inte användas av ammande mödrar.
Deferiprone must not be used by breast-feeding mothers.

Varje 1000 mg-tablett innehåller 1000 mg deferipron.
Each 1000 mg tablet contains 1000 mg deferiprone.

Deferipron skall inte tas av patienter som ammar.
Deferiprone must not be used by breast-feeding mothers.

Ferriprox 500 mg filmdragerade tabletter Deferipron.
Ferriprox 500 mg film-coated tablets deferiprone.

Det är okänt om deferipron utsöndras i bröstmjölk.
It is not known whether deferiprone is excreted in human milk.

Ferriprox innehåller den aktiva substansen deferipron.
Ferriprox contains the active substance deferiprone.

Deferipron metaboliseras i huvudsak till ett glukuronidkonjugat.
Deferiprone is metabolised predominantly to a glucuronide conjugate.

Innehållsdeklaration Den aktiva substansen är deferipron.
What Ferriprox contains The active substance is deferiprone.

Amning Det är inte känt om deferipron utsöndras i human mjölk.
Lactation It is not known whether deferiprone is excreted in human milk.

Innehållsdeklaration Det aktiva innehållsämnet är deferipron.
What Ferriprox contains The active substance is deferiprone.

Den aktiva substansen i Ferriprox, deferipron, är en järnkelatkomplexbildare.
The active substance in Ferriprox, deferiprone, is an‘ iron chelator.

Viktiga säkerhetspåminnelser för patienter som tar Ferriprox deferipron.
Important Safety Reminders for Patients taking Ferriprox deferiprone.

Deferipron absorberas snabbt från övre delen av mag-tarmkanalen.
Deferiprone is rapidly absorbed from the upper part of the gastrointestinal tract.

Ferriprox är ett läkemedel som innehåller den aktiva substansen deferipron.
Ferriprox is a medicine containing the active substance deferiprone.

Behandling med deferipron skall inte initieras om patienten lider av neutropeni.
Treatment with deferiprone should not be initiated if the patient is neutropenic.

Inga studier beträffande karciogenicitet på djur har utförts med deferipron.
No carcinogenicity studies in animals have been conducted with deferiprone.

Några interaktioner mellan deferipron och andra läkemedel har inte rapporterats.
Interactions between deferiprone and other medicinal products have not been reported.

Ferriprox 1000 mg filmdragerade tabletter Varje tablett innehåller 1000 mg deferipron.
Ferriprox 1000 mg film-coated tablets Each tablet contains 1000 mg deferiprone.

Biotransformering Deferipron metaboliseras i huvudsak till ett glukuronidkonjugat.
Biotransformation Deferiprone is metabolised predominantly to a glucuronide conjugate.

Låga zinknivåer i plasma har associerats med deferipron hos en minoritet av patienterna.
Low plasma zinc levels have been associated with deferiprone, in a minority of patients.

Ökade koncentrationer av leverenzymer i serum har rapporterats hos några patienter som tar deferipron.
Increased levels of serum liver enzymes have been reported in some patients taking deferiprone.

Den rekommenderade dosen deferipron kan därför vara mindre effektiv än deferoxamin.
Therefore deferiprone at the recommended dose could be less effective than deferoxamine.

Glukuronidens maximala serumkoncentration nås 2 till 3 timmar efter administrering av deferipron.
Peak serum concentrations of the glucuronide occur 2 to 3 hours after administration of deferiprone.

Säkerheten vid samtidig användning av deferipron och vitamin C har inte formellt studerats.
The safety of concurrent use of deferiprone and vitamin C has not been formally studied.

Därför rekommenderas inte samtidigt bruk av aluminiumbaserade syraneutraliserande medel och deferipron.
Therefore, it is not recommended to concomitantly ingest aluminium-based antacids and deferiprone.

Neutropeni/ Agranulocytos Deferipron har visat sig orsaka neutropeni, inklusive agranulocytos.
Neutropenia/ Agranulocytosis Deferiprone has been shown to cause neutropenia, including agranulocytosis.

Uppmana patienten att omedelbart sluta ta deferipron och alla andra läkemedel som kan ge upphov till neutropeni.
Instruct the patient to immediately discontinue deferiprone and all other medicinal products with a potential to cause neutropenia.

How to use "deferipron" in a Swedish sentence

Deferipron tas vanligen 3 gånger per dag.

Metabolism Deferipron metaboliseras huvudsakligen till ett glukuronidkonjugat.

Deferipron uppvisade inte några direkta mutagena egenskaper.

Man vet ännu inte om deferipron förvärrar leverfibros.

Eliminering Hos människan utsöndras deferipron huvudsakligen via njurarna.

Det är inte känt hur deferipron framkallar neutropeni.

Inga fall av överdosering med deferipron har rapporterats. 4.

Varningar/försiktighet: Deferipron har visat sig orsaka neutropeni, inklusive agranulocytos.

How to use "deferiprone" in an English sentence

Breast-feeding: It is not known if deferiprone passes into breast milk.

Neurological problems: Deferiprone may cause symptoms related to the nervous system.

Our hypothesis was that deferiprone would improve RV function more than deferoxamine.

Deferiprone can lower blood cells that help your body fight infections.

Doxorubin and deferiprone can cause severe side effects such as heart damage.

The long-term efficacy of deferiprone will be assessed.

Deferiprone is not as highly attracted to aluminium, copper or zinc.

Is it safe to use Deferiprone in patients with liver disease?

What conditions does Deferiprone Tablet treat?

Deferiprone is commonly used in combination with deferoxamine for enhanced iron clearance.